Alan C. Moss, MD
Boston University School of Medicine
Dept of Medicine

MBChB, Royal College of Surgeons in Ireland
PhD, University College Dublin

Alan Moss, MD, FACG, AGAF, FEBG, FRCPI is a clinician-scientist with an interest in Crohn's disease and Ulcerative Colitis (Inflammatory Bowel Disease, IBD). His clinical expertise is in management of IBD, and he is Director of the Crohn's & Colitis Program at Boston Medical Center. His research interests include microbial therapeutics, mucosal immunology and clinical outcomes. He has held grant funding from NIDDK, AGA, Helmsley Charitable Trust, and the Crohn's & Colitis Foundation. He has published over 120 research papers (h-index 28), including many cited in national and international practice guidelines. Dr Moss has held positions as Deputy-Editor of Crohn's & Colitis 360, and as Associate Editor for Journal of Crohn’s & Colitis (ECCO), Frontline Gastroenterology (BMJ) and the World Journal of Gastroenterology. He has served on the Nominating Committee of the IBD section of AGA, and the Professional Education and National Scientific Advisory Committee for the Crohn's & Colitis Foundation. He is a reviewer for national and international research bodies, including the NIDDK and European Research Council.

2019 Crohn’s & Colitis Foundation: Litwinn Pioneer’s Award
2019 School of Medicine, Dublin University: Visiting Professor in IBD
2018 Harvard Medical Faculty Physicians: Physician Leadership Program
2017 UCLA Digestive Disease Division: Visiting Professor
2017 University Clinic Barcelona: Visiting Professor
2015 Colorectal Research Center, University College Dublin: ‘State of the Art Lecture’
2014 American College of Gastroenterology: ‘Best of DDW’ Poster Nominee
2013 American College of Gastroenterology: IBD Abstract Research Award
2012 Harvard Medical School: Mentoring Award Nominee
2012 State University of New York: Goldwitz-Allen Memorial Lectureship
2012 Beth Israel Deaconess Medical Center: Rabb Award for GI Research
2011 American Gastroenterology Association: Abstract of Distinction Award
2008-2010 The Academy at Harvard Medical School: Excellence in Tutoring Award
2008 American College of Gastroenterology: Presidential Abstract Award
2006 American Gastroenterology Association: Fellow’s Travel Award
2005 American Society for Clinical Oncology: Foundation Merit Award
2004 European Crohn’s & Colitis Organization: Trainee Travel Award
2002 United European Gastroenterology Federation: Outstanding Abstract Award, Research
2002 University College Dublin: Excellence in Clinical Teaching

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Osterman MT, Scott FI, Fogt FF, Gilroy ED, Parrott S, Galanko J, Cross R, Moss A, Herfarth HH, Higgins PDR. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE). Inflamm Bowel Dis. 2021 Jan 19; 27(2):207-214. PMID: 32170946; DOI: 10.1093/ibd/izaa048;
  2. Harshe RP, Xie A, Vuerich M, Frank LA, Gromova B, Zhang H, Robles RJ, Mukherjee S, Csizmadia E, Kokkotou E, Cheifetz AS, Moss AC, Kota SK, Robson SC, Longhi MS. Endogenous antisense RNA curbs CD39 expression in Crohn's disease. Nat Commun. 2020 11 18; 11(1):5894. PMID: 33208731
  3. Chibbar R, Moss AC. Mesalamine in the Initial Therapy of Ulcerative Colitis. Gastroenterol Clin North Am. 2020 Dec; 49(4):689-704. PMID: 33121689
  4. Bhat S, Farraye FA, Moss AC. Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic. Am J Gastroenterol. 2020 09; 115(9):1532-1533.View Related Profiles. PMID: 32694291
  5. Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflamm Bowel Dis. 2020 Aug 20; 26(9):1291-1305. PMID: 32820340
  6. Robles RJ, Mukherjee S, Vuerich M, Xie A, Harshe R, Cowan PJ, Csizmadia E, Wu Y, Moss AC, Chen R, Robson SC, Longhi MS. Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 09; 14(6):818-830. PMID: 31693091; DOI: 10.1093/ecco-jcc/jjz182;
  7. Bai A, Moss A, Rothweiler S, Longhi MS, Wu Y, Junger WG, Robson SC. Author Correction: NADH oxidase-dependent CD39 expression by CD8+ T cells modulates interferon gamma responses via generation of adenosine. Nat Commun. 2020 06 10; 11(1):3036. PMID: 32522986; DOI: 10.1038/s41467-020-16314-5;
  8. Bhat S, Farraye FA, Moss A. Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19. Gastroenterology. 2020 May 18.View Related Profiles. PMID: 32425232
  9. Gubatan J, Mehigan GA, Villegas F, Mitsuhashi S, Longhi MS, Malvar G, Csizmadia E, Robson S, Moss AC. Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells. Inflamm Bowel Dis. 2020 05 12; 26(6):885-897. PMID: 31955203; DOI: 10.1093/ibd/izz330;
  10. Chen J, Haller CA, Jernigan FE, Koerner SK, Wong DJ, Wang Y, Cheong JE, Kosaraju R, Kwan J, Park DD, Thomas B, Bhasin S, De La Rosa RC, Premji AM, Liu L, Park E, Moss AC, Emili A, Bhasin M, Sun L, Chaikof EL. Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists. Sci Adv. 2020 01; 6(3):eaay8230.View Related Profiles. PMID: 31998845
Showing 10 of 150 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 150 publications over 19 distinct years, with a maximum of 20 publications in 2014

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease
Microbiomes, Human

Dr Moss has mentored medical students, residents and GI fellows on clinical and translation projects. These have led to 1st author papers on high-impact peer-reviewed journals, in addition to abstracts and research experience.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Moss's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department